“RNAi create opportunities that are difficult to achieve with conventional approaches” Paul Nioi (interview)
- Features -
Paul Nioi, SVP of Research at Alnylam Pharmaceuticals, discusses the development of RNA interference (RNAi) medicines, twenty years after Fire and Mello’s Nobel Prize — from scientific discovery to an
By European Scientist
-
LATEST NEWS
TOP ARTICLE THIS WEEK
“RNAi create opportunities that are difficult to achieve with conventional approaches” Paul Nioi (interview)
- Features -
Paul Nioi, SVP of Research at Alnylam Pharmaceuticals, discusses the development of RNA interference (RNAi) medicines, twenty years after Fire and Mello’s Nobel Prize — from scientific discovery to an
By European Scientist
-